Dr. Wang is Associate Professor of Biostatistics and Bioinformatics at Duke University. In the past ten years, he has been involved in the design and analysis of cancer clinical trials and translational studies in the Alliance. He serves as Associate Director of Biostatistics and the lead statistician for the Respiratory Committee of the Alliance. Dr. Wang’s methodological research is focused on the development of novel statistical methods for biomarker-integrated cancer clinical trials and for analyzing data from multiple sources subject to lack of generalizability and selection bias.

Dr. Spector received his MD from the University of Medicine and Dentistry of New Jersey–New Jersey Medical School in 1982. He is Associate Professor of Medicine and Associate Professor of Pharmacology & Cancer Biology at Duke University School of Medicine. Dr. Spector's current clinical interests include inflammatory breast cancer; HER2+ breast cancer; development of targeted therapies; developmental therapeutics; and personalized medicine.

Dr. Samsa received his PhD from the University of North Carolina at Chapel Hill in 1988. He is Associate Professor of Biostatistics and Bioinformatics and Assistant Professor in Medicine at Duke University School of Medicine. Dr. Samsa is an applied statistician whose primary interests are in study design, instrument development, information synthesis, practice improvement, effective communication of statistical results, and teaching.

Dr. Pang received his PhD from Yale University in 2008. He is Assistant Professor of Biostatistics and Bioinformatics at Duke University School of Medicine. Dr. Pang's current research interests include classification and predictive models, design and analysis of biomarker clinical trials, genomics and pathway analysis.

Dr. Owzar is Professor of Biostatistics and Bioinformatics at Duke University School of Medicine, Director of Bioinformatics at the Duke Cancer Institute, and Director of Biostatistics for the Radiation Countermeasures Center of Research Excellence at Duke. His research is focused on the development of statistical methods and computational tools for investigating the role of heritability on cancer drug induced adverse events. Dr.

Dr. Li received his PhD from the University of Michigan at Ann Arbor in 2008. He is Assistant Professor of Biostatistics and Bioinformatics at Duke University School of Medicine. Dr. Li's current research interests include survival analysis, dynamic treatment regimes, and clinical trials.

Dr. Jung received his PhD from the University of Wisconsin at Madison in 1992. He is Professor of Biostatistics and Bioinformatics at Duke University School of Medicine. Dr. Jung's current research interests include design of clinical trials, survival analysis, longitudinal data analysis, clustered data analysis, ROC curve analysis, and design and analysis of microarray studies.

Dr. Harpole received his MD from the University of Virginia School of Medicine in 1984. He is Professor of Surgery and Associate Professor in Pathology at Duke University School of Medicine. Dr. Harpole's current research interests include thoracic oncology; general thoracic surgery; benign and malignant disease of the lung, esophagus, and mediastinum; advanced airway and thoracoscopic surgery; hyperhidrosis palmaris; and mesothelioma.

Dr. Crawford received his MD from Ohio State University College of Medicine in 1974. He is Professor of Medicine and Chief of the Division of Medical Oncology at Duke University School of Medicine. Dr. Crawford's current research interests include lung cancer (small-cell and non-small-cell), chemotherapy, hematopoietic growth factors, and cancer clinical trials.